Do Any Subgroups of Resected Biliary Tract Cancers Patients That Benefit the Most from Adjuvant Chemoradiation Therapy?

Ann Surg Oncol. 2020 Dec;27(Suppl 3):934-936. doi: 10.1245/s10434-020-09128-8. Epub 2020 Sep 11.

Authors

Wen-Jie Ma¹, Rong-Xing Zhou²

Affiliations

¹ Department of Biliary Surgery, West China Hospital of Medicine, Sichuan University, Chengdu, Sichuan, People's Republic of China.
² Department of Biliary Surgery, West China Hospital of Medicine, Sichuan University, Chengdu, Sichuan, People's Republic of China. zhourongxing2014@hotmail.com.

PMID: 32918179
DOI: 10.1245/s10434-020-09128-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Biliary Tract Neoplasms* / therapy
Chemoradiotherapy, Adjuvant
Humans

Grants and funding